Disease | Predictor | Coefficient | SE | p Value | PAR (SE) (%)† |
---|---|---|---|---|---|
*Excludes village effects, even though they were significant in the dataset from 14 villages, as they could not be estimated for the remaining 11 villages in the full set. | |||||
†Population attributable risk estimated from individual inbreeding levels (see text). | |||||
SEs calculated by “delta” method. | |||||
CHD, coronary heart disease; F·1, inbreeding; LN_WT, weight; PAR, population attributable risk; VILL, village. | |||||
CHD | Constant | −6.20 | 1.27 | 0.000 | 34.3 (6.6)* |
SEX | 0.47 | 0.26 | 0.070 | ||
AGE·1 | 0.69 | 0.14 | 0.000 | ||
VILL | – | 0.022 | |||
F·1 | 26.63 | 4.88 | 0.000 | ||
Stroke | Constant | −3.28 | 0.71 | 0.000 | 26.3 (12.3) |
SEX | −0.30 | 0.40 | 0.464 | ||
AGE·1 | 0.34 | 0.20 | 0.095 | ||
F·1 | 13.37 | 5.85 | 0.022 | ||
Cancer | Constant | 10.17 | 6.27 | 0.105 | 23.2 (11.7) |
SEX | 0.83 | 0.54 | 0.128 | ||
AGE·1 | 0.02 | 0.20 | 0.909 | ||
LN_WT | −3.49 | 1.40 | 0.013 | ||
F·1 | 13.0 | 6.17 | 0.035 | ||
Depression | Constant | −3.86 | 0.58 | 0.000 | 42.2 (7.6) |
SEX | 0.69 | 0.31 | 0.028 | ||
AGE·1 | 0.02 | 0.14 | 0.896 | ||
F·1 | 24.54 | 4.43 | 0.000 | ||
Asthma | Constant | −3.74 | 0.80 | 0.000 | 47.6 (12.6) |
SEX | −0.40 | 0.45 | 0.374 | ||
AGE·1 | 0.36 | 0.23 | 0.110 | ||
F·1 | 23.10 | 6.04 | 0.000 | ||
Diabetes | Constant | −28.16 | 4.58 | 0.000 | 0 |
(type II) | SEX | 0.97 | 0.31 | 0.002 | |
AGE·1 | 0.31 | 0.14 | 0.027 | ||
LN_WT | 5.60 | 0.99 | 0.000 | ||
Gout | Constant | −14.90 | 4.08 | 0.000 | 31.0 (7.6) |
SEX | −0.17 | 0.29 | 0.552 | ||
AGE·1 | 0.38 | 0.14 | 0.006 | ||
LN_WT | 2.85 | 0.89 | 0.001 | ||
F·1 | 17.69 | 4.16 | 0.000 | ||
Peptic ulcer | Constant | −3.23 | 0.63 | 0.000 | 30.6 (10.5) |
SEX | −0.18 | 0.35 | 0.615 | ||
AGE·1 | 0.36 | 0.18 | 0.043 | ||
F·1 | 15.68 | 5.06 | 0.002 |